Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.47 |
| ▸ | CTSG | P08311 | 3/20 | 0.47 |
| ▸ | IAPP | P10997 | 4/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | JUN | P05412 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL984433 | 0.88 | ELANE (0.44) | ELANECTSGIAPPJUN | |
| SCHEMBL5589818 | 0.87 | ELANE (0.49) | ELANECTSGIAPP | |
| SCHEMBL5588855 | 0.86 | ELANE (0.49) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL8674511 | 0.85 | ELANE (0.38) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL218408 | 0.81 | IAPP (0.44) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL31290573 | 0.81 | IAPP (0.44) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL4527020 | 0.80 | KDM4E (0.38) | ELANECTSGGABRA1GABRB2 | |
| SCHEMBL68921 | 0.79 | IAPP (0.65) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL16527793 | 0.79 | JUN (0.44) | ELANECTSGIAPPJUN | |
| SCHEMBL670389 | 0.79 | ELANE (0.51) | ELANECTSGIAPPGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113727751-B | Microneedle device and method for manufacturing the same | 宝龄富锦生技股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | ELANE 3887/4885CTSG 3505/4885IAPP 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.